- Home
- GRVY vs CGEM Comparison
GRVY vs CGEM Comparison
Compare GRVY & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRVY
- CGEM
- Stock Information
- Founded
- GRVY 2000
- CGEM 2016
- Country
- GRVY South Korea
- CGEM United States
- Employees
- GRVY N/A
- CGEM N/A
- Industry
- GRVY Business Services
- CGEM Biotechnology: Pharmaceutical Preparations
- Sector
- GRVY Consumer Discretionary
- CGEM Health Care
- Exchange
- GRVY Nasdaq
- CGEM Nasdaq
- Market Cap
- GRVY 442.6M
- CGEM 482.7M
- IPO Year
- GRVY 2005
- CGEM 2021
- Fundamental
- Price
- GRVY $64.51
- CGEM $6.48
- Analyst Decision
- GRVY
- CGEM Strong Buy
- Analyst Count
- GRVY 0
- CGEM 8
- Target Price
- GRVY N/A
- CGEM $27.25
- AVG Volume (30 Days)
- GRVY 11.6K
- CGEM 525.8K
- Earning Date
- GRVY 11-11-2025
- CGEM 11-06-2025
- Dividend Yield
- GRVY N/A
- CGEM N/A
- EPS Growth
- GRVY N/A
- CGEM N/A
- EPS
- GRVY 8.59
- CGEM N/A
- Revenue
- GRVY $404,804,469.00
- CGEM N/A
- Revenue This Year
- GRVY N/A
- CGEM N/A
- Revenue Next Year
- GRVY N/A
- CGEM N/A
- P/E Ratio
- GRVY $7.38
- CGEM N/A
- Revenue Growth
- GRVY N/A
- CGEM N/A
- 52 Week Low
- GRVY $53.12
- CGEM $6.44
- 52 Week High
- GRVY $70.00
- CGEM $18.62
- Technical
- Relative Strength Index (RSI)
- GRVY 50.85
- CGEM 36.12
- Support Level
- GRVY $63.10
- CGEM $6.44
- Resistance Level
- GRVY $65.73
- CGEM $7.82
- Average True Range (ATR)
- GRVY 1.42
- CGEM 0.42
- MACD
- GRVY -0.13
- CGEM -0.11
- Stochastic Oscillator
- GRVY 48.62
- CGEM 2.34
About GRVY GRAVITY Co. Ltd. American Depository Shares
GRAVITY Co Ltd is an online and mobile games developer and publisher based in Korea. Its principal product, Ragnarok Online, is an online game which is available in more than 91 markets. Its games include Ragnarok Online, Requiem, Dragonica (Dragon Saga), Ragnarok Online II, Requiem Online, and R.O.S.E. Online. The company generates revenue from online games, mobile games and other sources including character based merchandise and animation.
About CGEM Cullinan Oncology Inc.
Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.